These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3414721)

  • 1. Visual compatibility of famotidine with commonly used critical-care medications during simulated Y-site injection.
    Jay GT; Fanikos J; Souney PF
    Am J Hosp Pharm; 1988 Jul; 45(7):1556-7. PubMed ID: 3414721
    [No Abstract]   [Full Text] [Related]  

  • 2. Visual compatibility of intravenous famotidine with selected drugs.
    Fong PA; Ward J
    Am J Hosp Pharm; 1989 Jan; 46(1):125-6. PubMed ID: 2565686
    [No Abstract]   [Full Text] [Related]  

  • 3. Visual compatibility of enalaprilat with commonly used critical care medications during simulated Y-site injection.
    Halpern NA; Colucci RD; Alicea M; Greenstein R
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):294-7. PubMed ID: 2544533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual compatibility of enalaprilat with selected intravenous medications during simulated Y-site injection.
    Thompson DF; Allen LV; Stiles ML
    Am J Hosp Pharm; 1990 Nov; 47(11):2530-1. PubMed ID: 2177585
    [No Abstract]   [Full Text] [Related]  

  • 5. Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection.
    Min DI; Brown T; Hwang GC
    Am J Hosp Pharm; 1992 Dec; 49(12):2964-6. PubMed ID: 1282779
    [No Abstract]   [Full Text] [Related]  

  • 6. The compatibility of nicardipine hydrochloride injection with various ICU medications during simulated Y-site injection.
    Halpern NA; Colucci RD; Alicea M; Greenstein R
    Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):250-4. PubMed ID: 2737791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration.
    Lor E; Sheybani T; Takagi J
    Am J Hosp Pharm; 1991 Apr; 48(4):744-6. PubMed ID: 2042678
    [No Abstract]   [Full Text] [Related]  

  • 8. Visual compatibility of tolazoline hydrochloride with various medications during simulated Y-site injection.
    Marquardt ED
    Am J Hosp Pharm; 1990 Aug; 47(8):1802-3. PubMed ID: 2389789
    [No Abstract]   [Full Text] [Related]  

  • 9. Visual compatibility of amsacrine with selected drugs during simulated Y-site injection.
    Trissel LA; Chandler SW; Folstad JT
    Am J Hosp Pharm; 1990 Nov; 47(11):2525-8. PubMed ID: 2278268
    [No Abstract]   [Full Text] [Related]  

  • 10. Visual compatibility of esmolol hydrochloride and various injectable drugs during simulated Y-site injection.
    Colucci RD; Cobuzzi LE; Halpern NA
    Am J Hosp Pharm; 1988 Mar; 45(3):630-2. PubMed ID: 2897164
    [No Abstract]   [Full Text] [Related]  

  • 11. Visual compatibility of acyclovir sodium with commonly used intravenous drugs simulated Y-site injection.
    Forman JK; Lachs JR; Souney PF
    Am J Hosp Pharm; 1987 Jun; 44(6):1408-9. PubMed ID: 3618621
    [No Abstract]   [Full Text] [Related]  

  • 12. Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1993 Feb; 50(2):300-4. PubMed ID: 8097617
    [No Abstract]   [Full Text] [Related]  

  • 13. Visual compatibility of labetalol hydrochloride injection with various injectable drugs during simulated Y-site injection.
    Colucci RD; Cobuzzi LE; Halpern NA
    Am J Hosp Pharm; 1988 Jun; 45(6):1357-8. PubMed ID: 3414706
    [No Abstract]   [Full Text] [Related]  

  • 14. Visual compatibility of ranitidine hydrochloride with commonly used critical-care medications.
    Chilvers MR; Lysne JM
    Am J Hosp Pharm; 1989 Oct; 46(10):2057-8. PubMed ID: 2816963
    [No Abstract]   [Full Text] [Related]  

  • 15. Visual compatibility of fentanyl citrate with selected drugs during simulated Y-site injection.
    Marquardt ED; Lam SS
    Am J Hosp Pharm; 1994 Mar; 51(6):811-2. PubMed ID: 8010323
    [No Abstract]   [Full Text] [Related]  

  • 16. Visual compatibility of idarubicin hydrochloride with selected drugs during simulated Y-site injection.
    Turowski RC; Durthaler JM
    Am J Hosp Pharm; 1991 Oct; 48(10):2181-4. PubMed ID: 1781476
    [No Abstract]   [Full Text] [Related]  

  • 17. Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients.
    Foushee JA; Meredith P; Fox LM; Wilder AG
    Am J Health Syst Pharm; 2020 Jul; 77(14):1144-1148. PubMed ID: 32537625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual compatibility of ciprofloxacin with selected components of total parenteral nutrient solutions during simulated Y-site injection.
    Percy LA; Rho JP
    Am J Hosp Pharm; 1993 Apr; 50(4):715-6. PubMed ID: 8470693
    [No Abstract]   [Full Text] [Related]  

  • 19. Visual compatibility of ciprofloxacin lactate with five broad-spectrum antimicrobial agents during simulated Y-site injection.
    Tucker DR; Sieradzan R
    Am J Hosp Pharm; 1988 Sep; 45(9):1910-1. PubMed ID: 3228127
    [No Abstract]   [Full Text] [Related]  

  • 20. Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection.
    Hanifah S; Nugroho B; Chabib L
    Anaesthesiol Intensive Ther; 2020; 52(1):23-27. PubMed ID: 32024349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.